Earth City, Missouri, Nov. 3, 2014 – Young Dental, a leading designer, manufacturer and marketer of consumables, instruments and other items used in the dental industry, today announced the acquisition of Oral-B Minute-Foam®, Centrays® and Centwins® trays and SUPATM disposable prophy angles together with the licensing of the Oral-B brand name for select professional oral care products. Oral-B will still continue to market over-the-counter retail products to the dental hygiene community.
“This relationship will allow us to expand the premium product offering available to dental professionals under the Oral-B brand name,” said Dave Sproat, CEO of Young. “We look forward to bringing new and innovative products to market through this relationship, which is core to our long-term growth strategy.”
This transaction combines two widely recognized and respected brands, both with deep expertise in dental products and strong customer relationships, to provide dental professionals with a comprehensive product offering that better equips them to serve their patients. The acquisition and license does not apply to over-the-counter retail dental products, including but not limited to items like toothpaste, toothbrushes, floss and mouth rinse.
Young Dental is a wholly-owned subsidiary of Young Innovations, Inc., which is a portfolio company of Linden Capital Partners. Kirkland & Ellis LLP served as legal counsel to Young.
About Young Innovations, Inc.
Young develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company’s consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves and other products. In addition, the Company offers a line of diagnostic products that includes panoramic X-ray machines and related supplies.
About Linden Capital Partners
Linden Capital Partners is Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is
based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.
